Cargando…
CEA as a blood-based biomarker in anal cancer
Background: The clinical utility of a blood-based biomarker in squamous cell carcinoma of the anus (SCCA) is unknown. We analyzed carcinoembryonic antigen (CEA), a commonly employed assay for patients with colorectal adenocarcinoma, as a serum biomarker for patients with biopsy-proven SCCA. Material...
Autores principales: | Hester, Robert, Advani, Shailesh, Rashid, Asif, Holliday, Emma, Messick, Craig, Das, Prajnan, You, Yi-Qian N., Taniguchi, Cullen, Koay, Eugene J., Bednarski, Brian, Rodriguez-Bigas, Miguel, Skibber, John, Wolff, Robert, Chang, George J., Minsky, Bruce D., Foo, Wai Chin, Rothschild, Nicole, Morris, Van K., Eng, Cathy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169063/ https://www.ncbi.nlm.nih.gov/pubmed/34084278 http://dx.doi.org/10.18632/oncotarget.27959 |
Ejemplares similares
-
Definitive Intensity-Modulated Chemoradiation for Anal Squamous Cell Carcinoma: Outcomes and Toxicity of 428 Patients Treated at a Single Institution
por: Holliday, Emma B, et al.
Publicado: (2022) -
Treatment of primary rectal adenocarcinoma after prior pelvic radiation: The role of hyperfractionated accelerated reirradiation
por: Jensen, Garrett, et al.
Publicado: (2018) -
Differential Spatial Gene and Protein Expression Associated with Recurrence Following Chemoradiation for Localized Anal Squamous Cell Cancer
por: Hernandez, Sharia, et al.
Publicado: (2023) -
Anal cancer treatment regimen considerations for the COVID-19 era: In regard to Tchelebi et al
por: Noticewala, Sonal S., et al.
Publicado: (2020) -
Patient-Reported Outcomes After Chemoradiation in Patients With Anal Cancer: A Qualitative Analysis
por: Corrigan, Kelsey L., et al.
Publicado: (2022)